Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

H Zylberberg, Y Benhamou, JL Lagneaux, A Landau… - Gut, 2000 - gut.bmj.com
BACKGROUND More severe liver disease together with a poor response rate to α interferon
argue for the use of more potent anti-hepatitis C virus (HCV) therapies in human …